Development of animal recombinant dna vaccine and its efficacy in foxes

Marie Paule Kieny, Jean Blancou, Richard Lathe, Pierre Paul Pastoret, Jean Paul Soulebot, Philippe Desmettre, Jean Pierre Lecocq*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

Rabies is prevalent in most parts of the world. An extensive reservoir of the disease is present in the population of wild animals. The fox in particular is a major vector of the disease in North America and Europe. Although attempts to control rabies by vaccination of wild carnivores with attenuated rabies virus have met with some success, this approach remains controversial. The potential of a recombinant vaccinia virus expressing the rabies glycoprotein for the protection of foxes against rabies was examined. Both the parental (wild-type) and recombinant viruses were found to be innocuous to foxes. Inoculation of live recombinant virus via the subcutaneous, intradermal, or oral routes uniformly elicited high titers of neutralizing antibodies, and animals that received 106plaque-forming units of the recombinant virus in bait resisted severe challenge with live rabies virus.

Original languageEnglish
Pages (from-to)S799-S802
JournalReviews of Infectious Diseases
Volume10
DOIs
Publication statusPublished - 1988

Fingerprint

Dive into the research topics of 'Development of animal recombinant dna vaccine and its efficacy in foxes'. Together they form a unique fingerprint.

Cite this